<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Biomarkers and Surrogate Endpoints in Clinical Studies To Support Effectiveness of New Animal Drugs; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Biomarkers and Surrogate Endpoints in Clinical Studies To Support Effectiveness of New Animal Drugs; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2021-10-06 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for industry (GFI) #267 entitled "Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs." The guidance describes FDA's current thinking with respect to incorporating biomarkers and surrogate endpoints into proposed clinical investigational protocols and applications for new animal drugs under the Federal Food, Drug, and Cosmetic Act (FD&C Act).</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2021-21688</p>
    <p><strong>Publication Date:</strong> 2021-10-06</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2021/10/06/2021-21688/biomarkers-and-surrogate-endpoints-in-clinical-studies-to-support-effectiveness-of-new-animal-drugs">https://www.federalregister.gov/documents/2021/10/06/2021-21688/biomarkers-and-surrogate-endpoints-in-clinical-studies-to-support-effectiveness-of-new-animal-drugs</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2021-21688</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
